Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 6.55 is 20% below its 5-year average of 8.20, near the low end of its 5-year range (6.02–23.94).
As of the fiscal period ended Tuesday, June 30, 2026. 13.28% below its 12-month average of 7.55.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 6.55.
CURRENT RATIO
6.55
CURRENT RATIO AVG TTM
7.55
CURRENT RATIO AVG 3Y
7.75
CURRENT RATIO AVG 5Y
8.20
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-13.28%
CURRENT VS 3Y AVG
-15.53%
CURRENT VS 5Y AVG
-20.18%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.60
median of 797 covered companies
CURRENT VS SECTOR MEDIAN
+81.86%
vs the sector median at left
PROCEPT BioRobotics Corporation
Market Cap
$991.20M
Current Ratio
6.55
TTM Avg
7.55
3Y Avg
7.75
5Y Avg
8.20
Market Cap
$983.38M
Current Ratio
5.04
TTM Avg
3.47
3Y Avg
3.89
5Y Avg
3.30
Market Cap
$979.53M
Current Ratio
15.08
TTM Avg
22.50
3Y Avg
27.08
5Y Avg
27.08
Market Cap
$966.65M
Current Ratio
16.33
TTM Avg
11.68
3Y Avg
16.13
5Y Avg
16.13
Market Cap
$1.02B
Current Ratio
1.44
TTM Avg
1.13
3Y Avg
1.10
5Y Avg
1.10
Market Cap
$1.03B
Current Ratio
6.04
TTM Avg
6.28
3Y Avg
6.71
5Y Avg
10.27
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PROCEPT BioRobotics Corporation (PRCT) | $991.20M | 6.55 | 7.55 | 7.75 | 8.20 |
| Pacira BioSciences, Inc. (PCRX)vs › | $983.38M | 5.04 | 3.47 | 3.89 | 3.30 |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $979.81M | 3.76 | 1.39 | 1.76 | 2.46 |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $979.53M | 15.08 | 22.50 | 27.08 | 27.08 |
| Aktis Oncology, Inc. (AKTS)vs › | $966.65M | 16.33 | 11.68 | 16.13 | 16.13 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 1.44 | 1.13 | 1.10 | 1.10 |
| Savara Inc. (SVRA)vs › | $953.94M | 10.13 | 12.79 | 15.81 | 14.15 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.03B | 6.04 | 6.28 | 6.71 | 10.27 |
| Kura Oncology, Inc. (KURA)vs › | $950.77M | 4.73 | 7.76 | 11.59 | 15.68 |
Current Ratio
6.55
Quick Ratio
5.35
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 6.55 |
| 2026-03-31 | 6.73 |
| 2025-12-31 | 6.85 |
| 2025-09-30 | 8.43 |
| 2025-06-30 | 9.20 |
| 2025-03-31 | 8.94 |
| 2024-12-31 | 9.07 |
| 2024-09-30 | 6.02 |
| 2024-06-30 | 7.51 |
| 2024-03-31 | 8.52 |
| 2023-12-31 | 7.63 |
| 2023-09-30 | 8.91 |
| 2023-06-30 | 6.40 |
| 2023-03-31 | 7.56 |
| 2022-12-31 | 7.73 |
| 2022-09-30 | 10.56 |
| 2022-06-30 | 16.01 |
| 2022-03-31 | 20.87 |
| 2021-12-31 | 20.08 |
| 2021-09-30 | 23.94 |
| 2021-06-30 | 12.83 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 7.59 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
